Daniel Nothelfer
Vice President, Business Development & Strategy, Life Sciences Innovations Group
Danaher
Rogier Janssens
President of Merck China and Managing Director of Merck Life Science China
Merck
Raju Kucherlapati
Paul C. Cabot Professor of Genetics and Professor of Medicine
Harvard Medical School
Nicolas Pierre
Vice President & General Manager, Life Science and Applied solutions
Leica Microsystems
Kaveh Kahen
President
Abcam
Issei Tsukamoto
Senior Vice President, Head of Business Development
Astellas Pharma Inc.
Jason Peng
Vice President and China Group Executive
Danaher
Alex Gu
Senior Vice President and President of Greater China
Medtronic
June Chang
President of Greater China
Boston Scientific
Vincent Guercio
Head of Strategy, Cytiva Genomic Medicine
Danaher
Amit Kakar
Managing Partner
Novo Holdings Asia
Xiaoping Ye
Chairman and Co-founder
Tigermed
Xingpeng Wang
President
Shanghai Hospital Association (SHA)
Chris Chen
Chief Executive Officer
WuXi Biologics
Guohong Shan
SVP, GM, Greater China, Central and South Asia
BeOne Medicine
Ling Liu
Chief Region Leader
Philips Greater China
Lily Dong
Vice President & General Manager, China Therapeutics (Mainland and HK, Macau)
Abbvie
Qiang Lyu
General Manager Hong Kong and Macau
AstraZeneca
Jeffery Li
Founding Partner & CEO
GL Capital
Michael Yi
Founder & Chairman, Co-Chief Investment Officer
Hillhouse Investment
Joel Yao
Partner
Sofinnova Partners - Biovelocita Strategy
Yuesheng Xin
Senior Managing Director
CITIC Capital
Minnie Fang
Chief Scientific Officer, China
Danaher
Adam Shen
Vice President, Head of M&A Asia
Danaher
Robert King
Co-Founder and Chief Investment Officer
1540 Ventures
Can Cui
Shareholder
Greenberg Traurig, LLP.
John Xu
Founder and President
Biorich International
Yihao Zhang
Managing Director
Warburg Pincus Asia
Jay Wang
CEO
EverBridge Group
Sandy Mou
Board Executive Director and CEO
Corxel
Guangzhong Yang
Founder and Chief Scientist
Institute of Medical Robotics at Shanghai Jiao Tong University
Chenxi Ouyang
Director of the Institute of Cellular Immunotherapy
Sino-US Precision Medicine Research Institute
Da Liu
Managing Director
CRCP Life Science Fund
Peiqiong Huo
Chief Representative for the Greater Bay Area and International Business
China Resources Pharmaceutical Commercial Group
Yaming Wang
Founder and CEO
Alphabet Health Group
Wenxin Yu
Deputy Director & Chief Healthcare Analyst
Guotai Haitong Securities Research Institute
Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences, Head of Asia Healthcare, Greater China Managing Partner
L.E.K. Consulting
Cheng Xing
Managing Partner
Sherpa Healthcare Partners
Fei Qi
Executive Director
Legend Capital
Jiangfeng Li
Partner and Head of Healthcare
Fortune Capital
Bo Ban
Partner
YuanBio Venture Capital
Kun Yang
Partner
Gaorong Capital
